Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Blesa

Showing results (51-60 of 158) with videos related to

Pageof 16
Sort By:
Cerebral Cortex (New York, N.Y. : 1991)|December 5, 2019
Atrophy of Basal Forebrain Initiates with Tau Pathology in Individuals at Risk for Alzheimer's DiseaseJose L Cantero, Mercedes Atienza, Carmen Lage, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 4, 2018
Challenges associated with biomarker-based classification systems for Alzheimer's diseaseIgnacio Illán-Gala, Jordi Pegueroles, Victor Montal, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2006
Reelin expression and glycosylation patterns are altered in Alzheimer's diseaseArancha Botella-López, Ferran Burgaya, Rosalina Gavín, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|May 20, 2016
One-Year Reference Norms of Cognitive Change in Spanish Old Adults: Data from the NEURONORMA SampleGonzalo Sánchez-Benavides, Jordi Peña-Casanova, Marta Casals-Coll, et al.
Dementia and Geriatric Cognitive Disorders|June 11, 2018
Distinct Clinical Features and Outcomes in Motor Neuron Disease Associated with Behavioural Variant Frontotemporal DementiaElena Cortés-Vicente, Janina Turon-Sans, Ellen Gelpi, et al.
Oncotarget|November 10, 2018
Obesity and Alzheimer's disease, does the obesity paradox really exist? A magnetic resonance imaging studyJordi Pegueroles, Amanda Jiménez, Eduard Vilaplana, et al.
Annals of Neurology|May 24, 2014
Cerebrospinal fluid β-amyloid and phospho-tau biomarker interactions affecting brain structure in preclinical Alzheimer diseaseJuan Fortea, Eduard Vilaplana, Daniel Alcolea, et al.
Journal of Clinical and Experimental Neuropsychology|December 15, 2011
Using artificial neural networks in clinical neuropsychology: high performance in mild cognitive impairment and Alzheimer's diseaseMaría Quintana, Joan Guàrdia, Gonzalo Sánchez-Benavides, et al.
Neurobiology of Aging|January 17, 2017
Cerebrospinal fluid mitochondrial DNA in the Alzheimer's disease continuumLaura Cervera-Carles, Daniel Alcolea, Ainara Estanga, et al.
Journal of Neurochemistry|May 22, 2009
Mild cholesterol depletion reduces amyloid-beta production by impairing APP trafficking to the cell surfaceCristina Guardia-Laguarta, Mireia Coma, Marta Pera, et al.
Pageof 16

Showing results (51-60 of 158) with videos related to

Sort By:
Pageof 16
Cerebral Cortex (New York, N.Y. : 1991)|December 5, 2019
Atrophy of Basal Forebrain Initiates with Tau Pathology in Individuals at Risk for Alzheimer's DiseaseJose L Cantero, Mercedes Atienza, Carmen Lage, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 4, 2018
Challenges associated with biomarker-based classification systems for Alzheimer's diseaseIgnacio Illán-Gala, Jordi Pegueroles, Victor Montal, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2006
Reelin expression and glycosylation patterns are altered in Alzheimer's diseaseArancha Botella-López, Ferran Burgaya, Rosalina Gavín, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|May 20, 2016
One-Year Reference Norms of Cognitive Change in Spanish Old Adults: Data from the NEURONORMA SampleGonzalo Sánchez-Benavides, Jordi Peña-Casanova, Marta Casals-Coll, et al.
Dementia and Geriatric Cognitive Disorders|June 11, 2018
Distinct Clinical Features and Outcomes in Motor Neuron Disease Associated with Behavioural Variant Frontotemporal DementiaElena Cortés-Vicente, Janina Turon-Sans, Ellen Gelpi, et al.
Oncotarget|November 10, 2018
Obesity and Alzheimer's disease, does the obesity paradox really exist? A magnetic resonance imaging studyJordi Pegueroles, Amanda Jiménez, Eduard Vilaplana, et al.
Annals of Neurology|May 24, 2014
Cerebrospinal fluid β-amyloid and phospho-tau biomarker interactions affecting brain structure in preclinical Alzheimer diseaseJuan Fortea, Eduard Vilaplana, Daniel Alcolea, et al.
Journal of Clinical and Experimental Neuropsychology|December 15, 2011
Using artificial neural networks in clinical neuropsychology: high performance in mild cognitive impairment and Alzheimer's diseaseMaría Quintana, Joan Guàrdia, Gonzalo Sánchez-Benavides, et al.
Neurobiology of Aging|January 17, 2017
Cerebrospinal fluid mitochondrial DNA in the Alzheimer's disease continuumLaura Cervera-Carles, Daniel Alcolea, Ainara Estanga, et al.
Journal of Neurochemistry|May 22, 2009
Mild cholesterol depletion reduces amyloid-beta production by impairing APP trafficking to the cell surfaceCristina Guardia-Laguarta, Mireia Coma, Marta Pera, et al.
Pageof 16